Infective Endocarditis

Abstract

To the Editor: In their review on infective endocarditis, Hoen and Duval (April 11 issue)¹ advocate that when valve replacement is performed during antibiotic treatment for native-valve infective endocarditis, antimicrobial therapy should not be switched to that recommended for prosthetic-valve infective endocarditis. Although supported by few data, such a strategy is in line with the 2009 European Society of Cardiology guidelines.² However, to our knowledge, only one retrospective study conducted at a single center with a small sample is available on the topic, and it showed cure rates that were similar regardless of the antimicrobial regimen administered.³ By contrast, the . . .